V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006882 | 310004080 | 1.67 | 62.7 | Palliative (P) | 2014-05-30 | 2015-02-19 | Bevacizumab 7.5mg/kg | N | N | 310013035 | BEVACIZUMAB |
| 310006883 | 310004080 | 1.47 | 88.5 | Palliative (P) | 2013-02-08 | 2018-03-28 | CARBOPLATIN + GEMCITABINE | 2 | N | 310013035 | GEMCARBO |
| 310006884 | 310004083 | null | 63.9 | Curative (C) | 2016-12-01 | 2016-12-07 | Trial Unspecified | 01 | N | 310013083 | TRIAL |
| 310006885 | 310004085 | null | 117.6 | Curative (C) | 2013-01-01 | 2013-06-20 | IVE | 02 | N | 310013083 | IVE |
| 310006886 | 310004087 | 1.7 | 91 | Curative (C) | 2013-03-18 | 2013-04-20 | Brentuximab Vedotin | N | N | 310013134 | BRENTUXIMAB |
| 310006887 | 310007693 | null | 94.3 | null | 2017-01-28 | 2017-01-29 | PEMBROLIZUMAB | 99 | N | 310013137 | PEMBROLIZUMAB |
| 310006888 | 310004088 | null | null | Curative (C) | 2013-06-25 | 2013-06-27 | Brentuximab | N | N | 310013152 | BRENTUXIMAB |
| 310006889 | 310004090 | 1.65 | 85.6 | Palliative (P) | 2014-11-13 | 2014-11-25 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 310013153 | CISPLATIN + GEMCITABINE |
| 310006890 | 310004094 | null | 59.1 | Palliative (P) | 2018-08-23 | 2018-09-13 | PEMBROLIZUMAB | N | null | 310013153 | PEMBROLIZUMAB |
| 310006891 | 310004094 | 1.65 | null | Palliative (P) | 2013-11-28 | 2013-11-28 | CISPLATIN + GEMCITABINE | 2 | null | 310013153 | CISPLATIN + GEMCITABINE |
| 310006892 | 310007697 | 1.47 | 59.1 | Palliative (P) | 2016-09-19 | 2016-09-20 | CARBOPLATIN + LIPOSOMAL DOX | 02 | null | 310013242 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006893 | 310007697 | 1.68 | 58.3 | Disease modification (D) | 2018-02-03 | 2018-02-03 | LEAM | 2 | N | 310013242 | LEAM |
| 310006894 | 310007697 | 1.81 | 73.5 | Adjuvant (A) | 2015-05-21 | 2015-05-28 | LEAM | N | N | 310013242 | LEAM |
| 310006895 | 310011206 | 1.57 | 55 | Curative (C) | 2016-10-16 | 2017-05-01 | Brentuximab | N | N | 310013343 | BRENTUXIMAB |
| 310006896 | 310004096 | 1.74 | 83 | Curative (C) | 2017-09-26 | 2017-09-26 | LEAM | N | null | 310013398 | LEAM |
| 310006897 | 310004096 | 1.77 | 68 | Palliative (P) | 2014-01-05 | 2014-01-22 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310013398 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006898 | 310004097 | null | 78 | Curative (C) | 2018-10-02 | 2018-11-07 | Brentuximab | N | N | 310013421 | BRENTUXIMAB |
| 310006899 | 310004097 | 1.68 | 89.5 | Disease modification (D) | 2015-07-17 | 2015-07-17 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310013421 | CISPLATIN + GEMCITABINE |
| 310006900 | 310004098 | 1.8 | 71.15 | Curative (C) | 2015-07-11 | 2015-08-26 | GEM-P | 02 | N | 310013495 | GEMCITABINE + PACLITAXEL |
| 310006901 | 310004100 | 1.53 | 24.9 | null | 2017-06-21 | 2017-06-21 | BEAM | 2 | N | 310013495 | BEAM |
| 310006902 | 310010625 | 1.73 | 58.2 | Palliative (P) | 2018-09-15 | 2018-09-15 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310013542 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006903 | 310004101 | null | null | Curative (C) | 2014-01-23 | 2014-03-29 | CISPLATIN + GEMCITABINE | N | null | 310013647 | CISPLATIN + GEMCITABINE |
| 310006904 | 310004102 | 1.64 | 66 | Palliative (P) | 2013-02-17 | 2013-02-26 | Brentuximab | N | N | 310013647 | BRENTUXIMAB |
| 310006905 | 310004102 | 1.65 | 77 | Palliative (P) | 2017-05-25 | 2017-06-13 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310013647 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006906 | 310004103 | 1.7 | 86 | Palliative (P) | 2018-03-01 | 2018-03-02 | Carboplatin + Liposomal Doxorubicin | N | N | 310013775 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006907 | 310007702 | 1.74 | 79.15 | Curative (C) | 2014-06-09 | 2014-08-12 | LEAM | N | Y | 310013782 | LEAM |
| 310006908 | 310004104 | 1.59 | 64.5 | Curative (C) | 2012-12-21 | 2013-03-08 | LEAM | N | N | 310013796 | LEAM |
| 310006909 | 310007703 | 1.64 | 47 | Palliative (P) | 2017-07-22 | 2017-08-03 | CISPLATIN + GEMCITABINE | N | N | 310013796 | CISPLATIN + GEMCITABINE |
| 310006910 | 310004106 | 1.79 | 131 | Curative (C) | 2013-06-21 | 2013-07-02 | BEAM | 02 | N | 310013899 | BEAM |
| 310006911 | 310004108 | null | 83.6 | Palliative (P) | null | 2015-10-23 | PEMBROLIZUMAB | N | null | 310013964 | PEMBROLIZUMAB |
| 310006912 | 310004109 | 1.58 | 96.3 | Neo-adjuvant (N) | 2015-12-17 | 2015-12-26 | IVE | N | null | 310013974 | IVE |
| 310006913 | 310004110 | null | 77 | Palliative (P) | 2014-12-15 | 2014-12-15 | PEMBROLIZUMAB | 02 | N | 310013994 | PEMBROLIZUMAB |
| 310006914 | 310007706 | null | 147.5 | Curative (C) | 2017-06-03 | 2017-09-01 | Brentuximab | N | N | 310014039 | BRENTUXIMAB |
| 310006915 | 310004111 | 1.61 | null | Palliative (P) | 2018-05-14 | 2018-05-22 | PEMBROLIZUMAB | N | N | 310014119 | PEMBROLIZUMAB |
| 310006917 | 310004114 | 1.56 | 62 | Palliative (P) | 2014-12-19 | 2015-01-06 | Carboplatin + Liposomal Doxorubicin | N | N | 310014178 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006918 | 310004117 | null | 139 | Palliative (P) | 2018-08-15 | 2018-08-25 | Brentuximab Vedotin | N | N | 310014178 | BRENTUXIMAB |
| 310006919 | 310004119 | 1.63 | 90 | Palliative (P) | 2015-12-08 | 2015-12-09 | GEM-P | 2 | N | 310014190 | GEMCITABINE + PACLITAXEL |
| 310006920 | 310004121 | 1.64 | 59.1 | Neo-adjuvant (N) | 2013-09-02 | 2013-09-08 | CISPLATIN + GEMCITABINE | N | null | 310014200 | CISPLATIN + GEMCITABINE |
| 310006923 | 310004124 | 1.65 | 51.6 | Curative (C) | 2014-11-26 | 2015-04-29 | GEMCITABINE | Y | null | 310014209 | GEMCITABINE |
| 310006924 | 310004124 | 1.74 | 76 | Disease modification (D) | null | 2016-08-01 | GEM-P | null | null | 310014209 | GEMCITABINE + PACLITAXEL |
| 310006925 | 310004125 | 1.7 | 89.1 | Disease modification (D) | 2017-02-21 | 2017-02-28 | LEAM | N | N | 310014225 | LEAM |
| 310006926 | 310004126 | 1.79 | null | Disease modification (D) | 2016-10-03 | 2016-10-03 | BEAM | N | N | 310014249 | BEAM |
| 310006927 | 310004127 | 1.63 | 42.8 | Curative (C) | 2014-01-16 | 2014-02-06 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | N | 310014256 | NOT MATCHED |
| 310006928 | 310004128 | 1.75 | 88.1 | Palliative (P) | 2013-12-06 | 2013-12-06 | GEMCITABINE | 02 | N | 310014261 | GEMCITABINE |
| 310006929 | 310004129 | 1.75 | 67.8 | Disease modification (D) | 2018-03-28 | 2018-05-05 | BEAM | N | N | 310014285 | BEAM |
| 310006930 | 310004129 | null | 79 | Palliative (P) | 2015-10-01 | 2016-03-05 | PEMBROLIZUMAB | N | N | 310014285 | PEMBROLIZUMAB |
| 310006931 | 310004130 | null | 14 | Curative (C) | 2015-11-21 | 2016-07-29 | Brentuximab | 02 | N | 310014287 | BRENTUXIMAB |
| 310006932 | 310004132 | 1.78 | null | Palliative (P) | 2013-11-20 | 2013-11-23 | Carboplatin + Liposomal Doxorubicin | 02 | N | 310014297 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006933 | 310009612 | null | 62.1 | Disease modification (D) | 2015-07-23 | 2015-07-24 | Brentuximab Vedotin | N | N | 310014324 | BRENTUXIMAB |
| 310006934 | 310009612 | 1.7 | 58.4 | Palliative (P) | null | 2016-03-18 | Carboplatin + Liposomal Doxorubicin | null | null | 310014324 | CARBOPLATIN + LIPOSOMAL DOX |